175 related articles for article (PubMed ID: 26920941)
1. Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.
Garelli E; Renaud S; Falcoz PE; Weingertner N; Olland A; Santelmo N; Massard G
Eur J Cardiothorac Surg; 2016 Aug; 50(2):322-8. PubMed ID: 26920941
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
3. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
5. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
Wang S; Zhou W; Zhang H; Zhao M; Chen X
Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
[TBL] [Abstract][Full Text] [Related]
6. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
7. Single-station skip-N2 disease: good prognosis in resected non-small-cell lung cancer (long-term results in skip-N2 disease).
Yazgan S; Ucvet A; Gursoy S; Samancilar O; Yagci T
Interact Cardiovasc Thorac Surg; 2019 Feb; 28(2):247-252. PubMed ID: 30085065
[TBL] [Abstract][Full Text] [Related]
8. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
9. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of tumor-infiltrating lymphocytes for patients with completely resected stage IIIA(N2) non-small cell lung cancer.
Feng W; Li Y; Shen L; Cai XW; Zhu ZF; Chang JH; Xiang JQ; Zhang YW; Chen HQ; Fu XL
Oncotarget; 2016 Feb; 7(6):7227-40. PubMed ID: 26811495
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
Liu JW; Li J; Lin G; Shang XQ
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
[TBL] [Abstract][Full Text] [Related]
12. Significant prognostic factors for completely resected pN2 non-small cell lung cancer without neoadjuvant therapy.
Uehara H; Nakao M; Mun M; Nakagawa K; Nishio M; Ishikawa Y; Okumura S
Ann Thorac Cardiovasc Surg; 2015; 21(4):345-53. PubMed ID: 25740454
[TBL] [Abstract][Full Text] [Related]
13. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
14. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in resected pathologic (p-) stage IIIA-N2, non-small-cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Kawano Y; Miyahara R; Takenaka K; Katakura H; Ishikawa S; Ito H; Wada H
Ann Surg Oncol; 2004 Jun; 11(6):612-8. PubMed ID: 15150069
[TBL] [Abstract][Full Text] [Related]
16. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio may predict the benefit of postoperative radiotherapy in non-small-cell lung cancer.
Urban D; Bar J; Solomon B; Ball D
J Thorac Oncol; 2013 Jul; 8(7):940-6. PubMed ID: 23695418
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications.
Andre F; Grunenwald D; Pignon JP; Dujon A; Pujol JL; Brichon PY; Brouchet L; Quoix E; Westeel V; Le Chevalier T
J Clin Oncol; 2000 Aug; 18(16):2981-9. PubMed ID: 10944131
[TBL] [Abstract][Full Text] [Related]
19. Survival following resection of clinically occult N2 non small cell lung cancer.
Dalton R; Keller S
J Cardiovasc Surg (Torino); 1994 Dec; 35(6 Suppl 1):13-7. PubMed ID: 7775526
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
